Finding Immune Nascent Type 1 Diabetes

Starting soon · Not applicable

Conditions studied: Healthy Adult, Type 1 Diabetes (T1D)

In brief

The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is: What form of recruitment communication is most effective for completing a type 1diabetes home screening kit? Researchers will compare two types of recruitment contact: email and mail based communication (low-touch) versus phone contact and follow-up by a research team member (high-touch). Participants will be contacted either via email/mail or by phone and asked if they want to complete a type 1 diabetes home screening kit.

Key facts

Study ID

NCT07663136

Run by

Indiana University

People needed

3800

Starts

2026-06-01

Expected to finish

2029-06-01

Last updated by the study team

2026-06-23

Who can join

Age: 1 and older, up to 99. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Participant must be in Indiana Biobank
• Participant must be able to provide consent
• Ages 1-99 including pregnant women

You may not qualify if…

• Refusal to sign informed consent for home screening is exclusionary for the home screening portion of the study
• While other medical conditions are allowable prior diabetes diagnosis is exclusionary for home autoantibody screening

Where it is running

• Indiana University School of Medicine — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.